title: The ATRA-dependent overexpression of the glutamate transporter EAAC1 requires RARbeta induction.
abstract: The mechanisms underlying trafficking and membrane targeting of EAAC1, the rodent counterpart of the human EAAT3 carrier for anionic amino acids, are well characterized. In contrast, much less is known on the regulation of Slc1a1, the gene that encodes for the transporter. We have recently found that all-trans retinoic acid (ATRA) stimulates EAAC1 expression and anionic amino acid transport in C6 rat glioma cells. We report here that the ATRA effect on EAAC1 activity was inhibited by the specific RAR antagonist LE540 and mimicked by Am80, a RAR agonist, but not by the RXR agonist HX630. Moreover, the ATRA-dependent induction of Slc1a1 mRNA required the synthesis of a protein intermediate and was not associated with changes in the messenger half-life. ATRA treatment induced the expression of both Rarb mRNA and RARbeta protein several hours before the induction of Slc1a1, while the mRNA for RFX1, a transcription factor recently involved in Slc1a1 transcription, was unchanged. In addition, Rarb silencing markedly inhibited the ATRA-dependent increase of both Rarb and Slc1a1 mRNAs. We conclude that in C6 glioma cells the induction of Slc1a1 by ATRA requires the synthesis of RARbeta, suggesting that the receptor is involved in the regulation of the transporter gene.
authors.affiliation: Department of Experimental Medicine, Unit of General and Clinical Pathology, University of Parma, via Volturno 39, 43100 Parma, Italy.
authors.forename: Massimiliano G
authors.initials: MG
authors.lastname: Bianchi
authors.forename: Gian C
authors.initials: GC
authors.lastname: Gazzola
authors.forename: Silvia
authors.initials: S
authors.lastname: Cagnin
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Kagechika
authors.forename: Ovidio
authors.initials: O
authors.lastname: Bussolati
mesh_terms: D000818:Animals; D001565:Benzoates / Q000494:pharmacology; D045744:Cell Line, Tumor; D003984:Dibenzazepines / Q000494:pharmacology; D050580:Excitatory Amino Acid Transporter 3 / Q000096:biosynthesis*; D020868:Gene Silencing; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D018168:Receptors, Retinoic Acid / Q000819:agonists / Q000096:biosynthesis* / Q000187:drug effects; D000072482:Retinoic Acid Receptor alpha; D013764:Tetrahydronaphthalenes / Q000494:pharmacology; D014212:Tretinoin / Q000494:pharmacology*
chemical_list: D001565:Benzoates; D003984:Dibenzazepines; D050580:Excitatory Amino Acid Transporter 3; C104183:LE 540; C000607071:RARA protein, human; D012333:RNA, Messenger; C000607073:Rara protein, rat; D018168:Receptors, Retinoic Acid; D000072482:Retinoic Acid Receptor alpha; C493398:Slc1a1 protein, rat; D013764:Tetrahydronaphthalenes; C082925:retinoic acid receptor beta; C061133:tamibarotene; D014212:Tretinoin